We are pioneering a new precision immunology ecosystem, mobilizing the clinical and data partners necessary to advance precision-first^TM therapeutics for both acute and chronic immune-driven illnesses.

We’ve accessed comprehensive data sets across sepsis, acute respiratory distress syndrome (ARDS) and rheumatoid arthritis, established clinical collaborations with more than 60 leading global health systems and entered into key partnerships to place our treatment response testing in thousands of hospitals around the world. With these partnerships in place, we believe we can fundamentally change the treatment of immune-driven illness.